Email this article 
Post a Comment Mycoplasma as one of causal factors of exacerbation of community-acquired pneumonia
- Authors: Shirinova F.V.1
-
Affiliations:
- Central Military Hospital
- Issue: Vol 37, No 5 (2020)
- Pages: 5-11
- Section: Original studies
- URL: https://ogarev-online.ru/PMJ/article/view/57666
- DOI: https://doi.org/10.17816/pmj3755-11
- ID: 57666
Cite item
Full Text
Abstract
Objective. To improve the effectiveness of treatment in exacerbation of community-acquired pneumonia among military recruits with chronic inflammatory respiratory tract processes.
Materials and methods. The study included the data from 266 medical histories of military recruits aged 18-26, who had community-acquired pneumonia confirmed clinically and X-ray, as well as concomitant chronic respiratory diseases and a spectrum of isolated microorganisms in the sputum. When pneumonia worsened in patients who were admitted to the hospital, the level of blood serum antibodies to M. hominis was measured.
Results. The study results showed that in military recruits, suffering from community-acquired pneumonia with concomitant chronic respiratory diseases, in case of undetected microorganisms in the sputum, the measurement of blood serum IgM antibodies to Mycoplasma hominis has a clinical value.
Conclusions. Mycoplasma hominis occupies a special place in the etiological structure of pathology among patients with community-acquired pneumonia.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
F. V. Shirinova
Central Military Hospital
Author for correspondence.
Email: Shirinovafidan@mail.ru
adjunct, doctor
Russian Federation, BakuReferences
- Belogorov S.B., Dolgikh V.V., Smirnov E.L. Analysis of the health status of young men of pre-conscription age in the Irkutsk region. Sibirskii meditsinskii zhurnal (Irkutsk) 2010; 1: 108–110 (in Russian).
- Govorin A.V., Gorbunov V.V., Luk'yanov S.А., Romanova E.N. Prognostic value of some clinical and laboratory parameters in patients with pneumonia during the influenza a (H1N1) pandemic. Pul'monologiya 2011; 1: 41–45 (in Russian).
- Es'kov A.S. On the results of the medical service of the Armed Forces in 2015 and the tasks for 2016. Voenno-meditsinskii zhurnal, 2016; 3: 3–12 (in Russian).
- Akimkin V.G., Mosyagin V.D., Korotchenko S.I., Malinovskii A.A., Kuchmin A.N., Kostinov M.P. et al. Features of epidemiology and prevention of community-acquired pneumonia in military collectives at the present stage. Zhurnal mikrobiologii, epidemiologii i immunobiologii 2010; 3: 8–13 (in Russian).
- Guchev I.A., Klochkov O.I., Sinopal'nikov A.I. Prevention of community-acquired pneumonia outbreaks with polysaccharide pneumococcal vaccine: analysis of prospects for use in Russian law enforcement agencies. Antibiotiki i khimioterapiya 2016; 1: 43–52 (in Russian).
- Sinopal'nikov A.I., Zaitsev A.A. Diagnosis and antibacterial therapy of severe community-acquired pneumonia. Voenno-meditsinskii zhurnal 2015; 336 (4): 16–25 (in Russian).
- Christ-Crain M., Opal S.M. Clinical review: The role of biomarkers in the diagnosis and management of community-acquired pneumonia. Crit Care 2010; 14 (1): 203.
- Niederman M.S. Management of community – acquired pneumonia: a review and update. Ther Adv respir Dis 2010; 23: 1–18.
- Schuetz P., Litke A., Albrich W.C., Mueller B. Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia. Curr Opin Infect Dis 2013; 26 (2): 159–167.
- Kharitonov M.A., Andreev V.A., Obolenskaya T.I. Community-acquired pneumonia in military personnel in local armed conflicts. Zdorov'e. Meditsinskaya ekologiya. Nauka 2012; 1–2: 133 (in Russian).
- Kuchmin A.N. Features of the immune status of military personnel who become ill with community-acquired pneumonia during combat operations. Voenno-meditsinskii zhurnal 2010; 331 (7): 12–18 (in Russian).
- Rachina S.A., Kozlov R.S. Modern approaches to microbiological diagnostics in community-acquired pneumonia. Pul'monologiya 2010; 5: 5–15 (in Russian).
- Feklisova L.V., Tselipanova E.E. Diagnosis and treatment of respiratory mycoplasmosis in children with obstructive syndrome and prolonged cough. Uchebnoe posobie Moscow:: MONIKI 2015; 22 (in Russian).
- Woodhead M. New guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2011 Dec; 38 (6): 1250-1251. doi: 10.1183/09031936.00105211
- Kim T.L., Alimova Kh.P., Satvaldieva E.S. New approaches to the diagnosis of complicated forms of pneumonia in children. Vestnik ekstrennoi meditsiny 2013; 1: 104–107 (in Russian).
Supplementary files
